Skip to main content

BC Cancer – Abbotsford

If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.

Tumour Group / SiteTrial TitleOpening Date
Breast
Assessment of breast cancer and response to systemic therapy before surgery using diffuse optical imaging technology. (DOB-Scan)
August 2018
Genitourinary
Androgen Suppression with Stereotactic Body or External Beam Radiation Therapy (ASSERT) - A Phase II randomized trial for intermediate and high risk prostate cancer
Jan. 6, 2017
CNSA PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (CE8)Jan. 2019
GastrointestinalA Phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KEYNOTE-859)
Mar. 26, 2019
Gyne
ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy)
Mar. 11, 2019
Breast
RANDOMIZED PHASE III TRIAL EVALUATING THE ROLE OF WEIGHT LOSS IN ADJUVANT TREATMENT OF OVERWEIGHT AND OBESE WOMEN WITH EARLY BREAST CANCER Breast Cancer WEight Loss Study (BWEL Study) (MAC20)
Jan. 2019
Breast
TAILOR RT: A RANDOMIZED TRIAL OF REGIONAL RADIOTHERAPY IN BIOMARKER LOW RISK NODE POSITIVE BREAST CANCER
Apr. 10, 2019

SOURCE: BC Cancer – Abbotsford ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2019 Provincial Health Services Authority